mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.29 |
0.01 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.02 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |